ArticleJournal of physiology and biochemistry2026
Inhibition of adipocyte-macrophage interaction via CSF1-CSF1R by curcumin.
Article in Journal of physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Adipocytes (Ad), macrophages (Mac), and lipopolysaccharide (LPS) in the adipose tissue (AT) of individuals with obesity may jointly contribute to obesity-induced pathogenesis. This study aims to examine the roles of adipocyte-macrophage interaction (AMI) and LPS in obesity-induced pathogenesis, as well as the effects of curcumin (Cur) on these interactions. An indirect co-culture model using conditioned media (CM) from 3T3-L1 Ad and J774A.1 Mac, with LPS, was used. AMI in AT and its association with systemic insulin resistance (IR) were further evaluated in a high-fat diet (HFD)-induced obese mouse model. Colony-stimulating factor 1 (CSF1), produced by Ad and Mac, additively enhanced LPS-induced Mac chemotaxis. Compared with LPS, CM from Mac and Ad differentially influenced inflammatory cytokine secretion by the other cell type, with some cytokines markedly increased by CM prepared with LPS. Furthermore, in Ad, LPS and Mac-derived CM reduced glucose transporter 4 (GLUT4) expression, with a greater reduction observed when combined. Cur inhibited some AMI-induced inflammation but did not restore AMI-repressed GLUT4 expression. Cur specifically suppressed CSF1 secretion in both cell types and inhibited colony-stimulating factor receptor (CSF1R) activation in Mac, thereby preventing AMI. AT from HFD-induced obese mice exhibited increased CSF1R and signal transducer and activator of transcription 3 activation but reduced perilipin 1 expression at AMI sites. These obese mice also showed IR and elevated inflammatory cytokine expression in AT, which Cur attenuated regardless of whether it was administered before or after obesity induction. Cur may inhibit obesity-induced inflammation and IR by preventing AMI.
Indexed as
Identifiers
42848190What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.